First AD

Second AD

Victoria M. Villaflor, MD, provides insights on the role of immune checkpoint inhibitors in treating nasopharyngeal carcinoma, focusing on the JUPITER and POLARIS-2 clinical trials.

Overview of the JUPITER and POLARIS-2 Trials

Video content above is prompted by the following:

Have you had clinical experience with immune checkpoint inhibitors in combination with chemotherapy for your patients with NPC?

Please give your thoughts on the JUPITER and POLARIS-2 trials in NPC.

Head & Neck Cancers

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer. 

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Clinical Advances in Nasopharyngeal Carcinoma

Yale Cancer Center